Advanced Therapeutics Pharmaceutical Outsourcing Market to Surge at a CAGR of 4.4% by 2034 Amid Growing Demand for Personalized Medicine

Future Market Insights United Kingdom United States of America

was valued at US$ 7,197.8 million in 2023. The market is projected to reach US$ 11,698.1 million, surging at a CAGR of 4.4% by 2034.

Request Exclusive Sample Report: Advanced Therapeutics Pharmaceutical Outsourcing Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-18755

Advanced therapeutics encompass a range of cutting-edge and innovative treatments, including gene therapies, cell therapies, mRNA-based therapies, and other personalized and precision medicine approaches. Pharmaceutical companies often collaborate with external partners, such as contract development and manufacturing organizations (CDMOs) and contract research organizations (CROs) service providers, to leverage their expertise, infrastructure, and capabilities in the complex and rapidly evolving field of advanced therapeutics.

The advanced therapeutics pharmaceutical outsourcing market is propelled by an array of drivers and opportunities that underscore its pivotal role in the dynamic landscape of advanced therapeutic development. Rapid advancements in gene therapy, cell therapy, and mRNA technologies are catalysts for outsourcing services, demanding specialized expertise to navigate their complexities. 

The escalating pipeline of innovative therapies, especially those targeting rare diseases and oncology, provides a fertile ground for outsourcing partners to offer indispensable support in development and manufacturing. The globalization of clinical trials, driven by the trend toward personalized medicine, particularly in oncology, further amplifies the demand for outsourcing services with a global reach.

Technological innovations in manufacturing, such as continuous manufacturing and automation, present opportunities for outsourcing partners to enhance efficiency and scalability in producing advanced therapeutics. Strategic collaborations and partnerships between pharmaceutical companies, academic institutions, and outsourcing entities foster innovation and collectively address challenges in the rapidly evolving field. 

As the market evolves, opportunities lie in expanding outsourcing services to cover a broader spectrum of advanced therapeutic modalities, meeting pharmaceutical clients' diverse and dynamic needs.

Scope of the Report

Attribute

Details

Estimated Market Size (2024)

US$ 7,592.8 million

Projected Market Size (2034)

US$ 11,698.1 million

Anticipated Growth Rate (2024 to 2034)

4.4 %

Forecast Period

2024 to 2034

Historical Data Available for

2019 to 2023

Market Analysis

US$ million for Value

Key Countries Covered

 United States Canada Mexico Brazil Chile China Japan Poland

 

 South Korea Germany France Spain Italy BENELUX Nordic Countries United Kingdom BENELUX

 

 Hungary Romania India Association of Southeast Asian Nations Countries Australia and New Zealand GCC Countries South Africa Türkiye

 

Key Market Segments Covered

Advanced Therapeutics Pharmaceutical Outsourcing Industry Segmentation

By Service Type:Contract Research Organizations (CROs)Contract Development and Manufacturing Organizations (CDMOs)By Indication:OncologyNeurologyCardiologyInfectious DiseasesOthersBy Therapy:Cell TherapyGene TherapyRNA-based TherapiesOthersBy Phases:Preclinical ServicesClinical ServicesCommercial Manufacturing and PackagingBy Region:North AmericaLatin AmericaEast AsiaSouth Asia and PacificWestern EuropeEastern EuropeMiddle East and Africa

Key Companies Profiled

Croda International PlcCharles River Laboratories International, Inc.Catalent, Inc.QuintilesIMS (IQVIA)Parexel International CorporationICON plcPPD, Inc. (Thermo Fisher Scientific)LabCorp (Laboratory Corporation of America Holdings)Syneos HealthWuXi AppTec

 

Lonza GroupPiramal Pharma SolutionsSGS SAEvotec SECMC Biologics (Now AGC Biologics)Marken (A UPS Company)Cytovance BiologicsSamsung BiologicsCordenPharma

 

Recipharm ABVetter Pharma International GmbHCryoport Systems, Inc.ProPharma GroupFujifilm Diosynth BiotechnologiesMedpaceNovotech Pty Ltd.Axcella Health Inc.CelerionAshland

 

 

Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.

Key Takeaways from the Market Study

By service type, contract development and manufacturing organizations (CDMOs) are expected to surge at a CAGR of surge at a CAGR of 3.7% by 2034.By indication, oncology held a 46.1% market value share in 2023. By therapy, gene therapy held the leading share in the market of 49.6% in 2023. By phases, commercial manufacturing, and packaging segment dominates with the leading share, accounting for 54.9% in 2023. North America is the primary region, holding a substantial value share of 37.3% in 2023. 

"Development and manufacturing of advanced therapeutics, such as gene and cell therapies, is responsible for the growth of the advanced therapeutics pharmaceutical outsourcing market worldwide," says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Competitive Landscape

The advanced therapeutics pharmaceutical outsourcing market encourages collaborative innovation, with pharmaceutical companies and outsourcing partners working together to advance technologies, overcome challenges, and bring novel therapies to market. 

For instance,

In June 2023, KD Pharma Group and DUDE CHEM announced their strategic partnership to usher in a new era of digital innovation, greatly enhancing the efficiency and safety of pharmaceutical drug and therapy development. In January 2021, Thermo Fisher Scientific, Inc. acquired the viral vector business from Henogen S.A (Groupe Novasep SAS). 

Want more insights?

Future Market Insights brings a comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2019 to 2034. The global advanced therapeutics pharmaceutical outsourcing market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights into the advanced therapeutics pharmaceutical outsourcing market segment based on service type – (contract research organizations (CROs), contract development and manufacturing organizations (CDMOs)), indication (oncology, neurology, cardiology, infectious diseases, others), therapy (cell therapy, gene therapy, RNA-based therapies, others) phases (preclinical services, clinical services, commercial manufacturing, and packaging) across seven major regions.

Request to Access the Detail Research Methodology from here!

About Healthcare Division at Future Market Insights (FMI)

Future Market Insights (FMI) facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you to devise innovation-driven trajectories for your business. Know more about our sector coverage here.

About the Author:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

 Explore FMI's Extensive Coverage in the Healthcare Domain:

Vitamin and Mineral Supplement Market by Vitamins and Minerals, from 2024 to 2034. – Review and Request to Access the Sample PDF.Infection Prevention Market Forecast by Consumables and Disinfectors Products from 2024 to 2034. - Review and Request to Access the Sample PDF.Distance Health Technology Market Analysis by Telemedicine Hardware and Software from 2024 to 2034. - Review and Request to Access the Sample PDF.Topical Pain Relief Market Analysis by Creams, Gels, Patch, and Spray Formulations, 2024 to 2034. - Review and Request to Access the Sample PDF.Baby Safety Products Market by Product Type, Distribution Channel & Region | Forecast 2023 to 2033. - Review and Request to Access the Sample PDF.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai and has delivery centers in the United Kingdom, the United States, and India. FMI's latest market research reports and industry analysis helps businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition.

Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: [phone]
For Sales Enquiries: [e-mail]
Website: https://www.futuremarketinsights.com
LinkedIn | Twitter | Blogs | YouTube

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/advanced-therapeutics-pharmaceutical-outsourcing-market-to-surge-at-a-cagr-of-4-4-by-2034-amid-growing-demand-for-personalized-medicine-302035554.html